Built for Accuracy.
Trusted for Outcomes.
At NTL Biotech, our goal is to provide sensible options to specimen testing to increase productivity, maximize profitability, and to streamline testing operations. Providing insightful inventions to facilitate these improvements we plan, engineer, and implement advancements to laboratory hardware and supplies.
From specimen to result.
One integrated system.
NTL Biotech's platform spans the complete molecular diagnostic workflow — automated extraction hardware, validated multiplex reagent panels, and structured reporting — developed together to operate as a cohesive system.
Integrated workflow vs. fragmented supply.
"Our products are developed in the same environments where they are deployed."
NTL Biotech was founded by professionals from the reference laboratory industry who identified the operational gaps that fragmented diagnostic supply chains create. Every product originates from a specific workflow problem encountered in a high-complexity production laboratory.
We design, develop, and manufacture in the United States — and our R&D team works in active clinical testing environments.
Automated nucleic acid extraction
for molecular diagnostics.
Two benchtop platforms. One extraction kit. Engineered end-to-end for high-complexity diagnostic workflows.
Extraction Kits
A product hierarchy designed around clinical workflows — featuring our flagship Blood Extraction Kit and DNA/RNA dual extraction kits for infectious disease applications.
NTL Biotech’s Extraction Kits are an innovative approach for all uses of extracted RNA/DNA in applications such as real-time PCR and Next Generation Sequencing. The extraction kit system of plates uses magnetic bead-based technology for high yield extraction. This ensures that the maximum amount of nucleic acid is captured for downstream use applications. Each extraction kit includes components for the lysis, wash, and elution of specimens into purified nucleic acid.
Validated multiplex qPCR panels
for clinical diagnostics.
NTL Biotech's reagent portfolio spans sexual and reproductive health, respiratory pathogens, UTI, and wound diagnostics — all validated with NTL extraction systems.
STI / Women's Health Panel
11-target multiplex qPCR panel. Vaginal swab and first-catch urine.
All products & diagnostic systems.
A reference index of the full NTL Biotech portfolio — extraction platforms, validated reagent panels, and reporting software.
End-to-end molecular diagnostics from a single source.
From automated nucleic acid extraction systems through validated multiplex qPCR panels to structured reporting — the full NTL Biotech portfolio is designed to work as a cohesive, validated system.
Molecular science applied to agriculture
and veterinary health.
NTL Biotech extends its molecular diagnostic expertise to agricultural pathogen surveillance, veterinary diagnostics, and food safety.
The same validated platform.
Extended to new applications.
The molecular platforms NTL Biotech developed for clinical diagnostics — automated extraction, multiplex qPCR, and structured reporting — translate directly to agricultural and veterinary laboratory challenges.
Molecular pathogen detection is becoming the standard of practice in agricultural and veterinary settings, driven by the same demands for speed, accuracy, and scale that transformed clinical diagnostics.
Veterinary Solutions
Multiplex PCR panels for livestock and companion animal pathogen detection. Herd-level surveillance tools developed with veterinary diagnostic laboratories.
Applications include bovine, porcine, and avian respiratory pathogens, tick-borne disease, and food animal pre-harvest diagnostics.
Agricultural Solutions
Molecular diagnostics for crop pathogen surveillance, soil microbiome analysis, and plant disease identification. Scalable platforms for field-adjacent laboratory environments.
Applications include fungal and bacterial plant pathogens, soil pathogen mapping, and crop disease rapid response protocols.
Creating safer farms, healthier animal populations, and a more secure food supply through molecular science.
By extending the precision of molecular diagnostics from clinical to agricultural and veterinary settings, NTL Biotech is contributing to the resilience of global food systems.
Clinical interpretation layer
for molecular diagnostic reports.
LabLens sits between your laboratory’s report output and an interpretation layer — converting results into clear Positive / Negative interpretations and decision-support summaries. It integrates with reporting workflows but is not a full LIS replacement.
Positive / Negative.
Clear interpretation.
LabLens processes laboratory report outputs and applies an interpretation layer that converts results into clear Positive / Negative calls with structured report formatting. It can integrate into LIS-like reporting flows (inputs and outputs) but it is not intended to replace a full laboratory information system.
LabLens is available to NTL Biotech instrument customers. Access is provisioned with Aarya i or Amaya i deployment.
We're here to assist.
For product enquiries, instrument information, distributor partnerships, or technical support — contact the appropriate NTL Biotech team.
Skokie, IL 60076
United States
9:00 am – 5:00 pm CST